Pharmacological Proposal Approach to Managing Chronic Pain Associated with COVID-19

Biomedicines. 2023 Jun 24;11(7):1812. doi: 10.3390/biomedicines11071812.

Abstract

Background: Post-COVID syndrome is widespread and chronic pain associated with this syndrome is increasingly being seen in pain clinics. Understanding and managing Chronic Post-COVID Pain (CPCoP) is essential in improving the quality of life of patients. Relevant sections: Identify the types of pain associated with post-COVID syndrome and look for ways to treat them.

Results and discussion: Based on our experience, we have identified five groups within CPCoP: (1) chronic pain post-hospitalization in intensive care or long hospitalizations, (2) pain associated with rehabilitation, (3) exacerbation of existing chronic pain pre-COVID-19 infection, (4) central and peripheral neuropathic pain post-COVID-19 infection, (5) chronic pain post vaccination. To fight against misinformation, we created an information capsule for doctors, nurses, and other health workers at a conference via the ECHO* program, delivered 2-3 times a year.

Conclusions: In pandemic and post-pandemic periods, it is important to determine the sequelae that a disease can leave in the general population, and to understand and treat them. The model proposed may serve as an inspiration to other pain centers to treat the increasing number of patients with CPCoP.

Keywords: chronic pain post vaccination; chronic post-COVID pain 2; neuropathic pain; post-COVID syndrome 3 rehabilitation pain.

Publication types

  • Review

Grants and funding

This research received no external funding.